{
    "2018-10-03": [
        [
            {
                "time": "2018-10-03",
                "original_text": "Merck CEO sees a disintermediation in pharma like the cable industry",
                "features": {
                    "keywords": [
                        "Merck",
                        "CEO",
                        "disintermediation",
                        "pharma",
                        "cable industry"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-10-03",
                "original_text": "How Did Pharmaceutical ETFs Perform in Q3 2018?",
                "features": {
                    "keywords": [
                        "Pharmaceutical",
                        "ETFs",
                        "Q3",
                        "2018",
                        "performance"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-03",
                "original_text": "Novartis, Boston Pharma Ink Deal for 3 Anti-Infective Drugs",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Boston Pharma",
                        "Deal",
                        "Anti-Infective",
                        "Drugs"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-10-03",
                "original_text": "Notable ETF Inflow Detected - SPYG, ABT, INTC, PFE",
                "features": {
                    "keywords": [
                        "ETF",
                        "Inflow",
                        "SPYG",
                        "ABT",
                        "INTC",
                        "PFE"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "technology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-03",
                "original_text": "A Look at Elanco, Eli Lilly’s Animal Health Business",
                "features": {
                    "keywords": [
                        "Elanco",
                        "Eli Lilly",
                        "Animal Health",
                        "Business"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "animal health"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-03",
                "original_text": "Health Care Sector Update for 10/03/2018: JNJ, PFE, AMGN, MRK, ABT, ELGX, NVCN, KALA",
                "features": {
                    "keywords": [
                        "Health Care",
                        "Sector",
                        "Update",
                        "JNJ",
                        "PFE",
                        "AMGN",
                        "MRK",
                        "ABT",
                        "ELGX",
                        "NVCN",
                        "KALA"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-04",
                "original_text": "Bristol-Myers Squibb Company (BMY) Ex-Dividend Date Scheduled for October 04, 2018",
                "features": {
                    "keywords": [
                        "Bristol-Myers Squibb",
                        "BMY",
                        "Ex-Dividend",
                        "Date",
                        "Scheduled"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-03",
                "original_text": "How Have Eli Lilly’s Endocrine Products Been Performing?",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Endocrine",
                        "Products",
                        "Performing"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-03",
                "original_text": "Lex letter from New York: chiefs checked",
                "features": {
                    "keywords": [
                        "Lex letter",
                        "New York",
                        "chiefs",
                        "checked"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "general"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-10-03",
                "original_text": "Wide Moat Surrounds Pfizer's Solid Foundation",
                "features": {
                    "keywords": [
                        "Wide Moat",
                        "Pfizer",
                        "Solid Foundation"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-10-03",
                "original_text": "The 5 Best Dow Jones Stocks to Buy Now",
                "features": {
                    "keywords": [
                        "Dow Jones",
                        "Stocks",
                        "Buy",
                        "Now"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-03",
                "original_text": "With Hemlibra, Roche seeks to break into tight hemophilia circle",
                "features": {
                    "keywords": [
                        "Hemlibra",
                        "Roche",
                        "hemophilia",
                        "circle"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}